Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
The potential for antitumor vaccination in acute myelogenous leukemia
Robert J. Arceci
Research output
:
Contribution to journal
›
Review article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The potential for antitumor vaccination in acute myelogenous leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Myeloid Leukemia
100%
Tumor Vaccination
100%
Patients with Cancer
50%
Drug Resistance
25%
Immune Response
25%
Vaccine Development
25%
Hematopoietic Stem Cell Transplantation
25%
Leukemic Cells
25%
Vaccine Approaches
25%
Complete Remission
25%
Long-term Survival
25%
NewHope
25%
Immunobiology
25%
Chemotherapeutic Regimens
25%
Vaccine Therapy
25%
Tumor Cell Resistance
25%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
100%
Acute Myeloid Leukemia
100%
Malignant Neoplasm
50%
Neoplasm
25%
Remission
25%
Drug Resistance
25%
Long Term Survival
25%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Chemotherapy
50%
Tumor Cell
25%
Long Term Survival
25%
Drug Resistance
25%
Hematopoietic Stem Cell Transplantation
25%
Hope
25%
Immunology
25%